View Author
scopus: 7005539852

Rijken, D.C.

(Dingerman Rijken)


patient level thrombosis plasma study factor blood control plasminogen inhibitor brinolysi venous thrombosis venou activity fi brinolysis brinolytic thromb risk factors group disease activator signi protein assay effect thrombin tafi levels activation haemost sample fi brinolytic system signi ficantly result association ethanol plasma fi brinolytic antigen plasma levels risk factor fi brin plasmin system difference fi brinolytic capacity liver venous thromboembolism analysis plasminogen activator inhibitor ficant fibrinolysi subject syndrome rosendaal fr fi brinogen tissue-type plasminogen activator alcohol table fibrinolytic consumption polymorphism brinogen stroke ischemic stroke haemostasi clot fi rmness peptide j thromb haemost ischemic budd-chiari syndrome fviii 1 levels value ficantly concentration increase haplotype thromboembolism tafia receptor correlation




10 Most Recent Publications

Oxidized high-density lipoprotein reduces blood clot firmness (Article)
Talens, S. Malfliet, J.J.M.C. Leebeek, F.W.G. Rijken, D.C.
2013-03-01
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease (Article)
Wee, E.M. de Klaij, K. Rijken, D.C. Leebeek, F.W.G. Eikenboom, H.C.J. Bom, J.G. van der Fijnvandraat, K. Laros-Van Gorkom, B.A.P. Mauser-Bunschoten E. Meijer, K. Goverde, G. Linden, P.W.G. van der
2011-10-06
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome (Article)
Talens, S. Hoekstra, J. Leebeek, F.W.G. Rijken, D.C. Dirkx, S.P.G. Murad, S.D. Trebicka, J. Elias, E. Primignani, M. García-Pagán, J.C. Valla, D.C. Janssen, H.L.A.
2011-05-01
High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease (Article)
Bruijne, E.L.E. de Gils, A. Rijken, D.C. Maat, M.P.M. de Guimarães, A.H.C. Poldermans, D. Declerck, P.J. Leebeek, F.W.G.
2011-03-01
Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: Similarities and differences (Article)
Smalberg, J.H. Kruip, M.J.H.A. Janssen, H.L.A. Rijken, D.C. Leebeek, F.W.G. Maat, M.P.M. de
2011-03-01
The effect of ethanol and its metabolism on fibrinolysis (Article)
Pieters, M. Vorster, H.H. Jerling, J.C. Venter, C.S. Kotze, R.C.M. Bornman, E. Malfliet, J.J.M.C. Rijken, D.C.
2010-10-01
Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome (Article)
Hoekstra, J. Guimarães, A.H.C. Primignani, M. Garcia-Pagan, J.C. Valla, D.C. Rijken, D.C. Janssen, H.L.A. Leebeek, F.W.G. Murad, S.D. Malfliet, J.J.M.C. Plessier, A. Hernandez-Guerra, M. Langlet, P. Elias, E. Trebicka, J.
2010-01-14
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: The ATTAC study (Article)
Bruijne, E.L.E. de Gils, A. Leebeek, F.W.G. Guimarães, A.H.C. Dippel, D.W.J. Deckers, J.W. Meiracker, A.H. van den Poldermans, D. Rijken, D.C. Declerck, P.J. Maat, M.P.M. de
2009-05-29
Hypofibrinolysis is a risk factor for arterial thrombosis at young age (Article)
Guimarães, A.H.C. Bruijne, E.L.E. de Lisman, T. Dippel, D.W.J. Deckers, J.W. Poldermans, D. Rijken, D.C. Leebeek, F.W.G.
2009-04-01
New insights into the molecular mechanisms of the fibrinolytic system (Article)
Rijken, D.C. Lijnen, H.R.
2009-01-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile